SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-067330
Filing Date
2020-03-09
Accepted
2020-03-09 17:16:35
Documents
2
Group Members
FHMLS IX, L.L.C.FHMLS IX, L.P.JAMES N. TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d870234dsc13d.htm SC 13D 145149
2 EX-A d870234dex99a.htm EX-99.A 8999
  Complete submission text file 0001193125-20-067330.txt   155851
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences IX, L.P. (Filed by) CIK: 0001720320 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Subject) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91451 | Film No.: 20698868
SIC: 2836 Biological Products, (No Diagnostic Substances)